Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
  • Menu
  • Articles
    • Author Correction
    • Autoimmune Diseases
    • Cardiovascular Conditions
    • Commentary
    • Dermatological Diseases
    • Endocrine Diseases
    • Gastrointestinal Conditions
    • General Indications
    • Hematology
    • Hereditary Genetic Disorders
    • Infectious Diseases
    • Methodology and Healthcare Policy
    • Nephrologic/Hepatologic Conditions
    • Neurological Diseases
    • Oncology
    • Ophthalmology
    • Other Conditions
    • Psychological Conditions
    • Respiratory Diseases
    • Trauma Induced Conditions
    • Urological/Gynecological Diseases
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Journal Policies
  • For Reviewers
  • search

    Sorry, something went wrong. Please try your search again.
    ×

    • Articles
    • Blog posts

RSS Feed

Enter the URL below into your favorite RSS reader.

https://jheor.org/feed
×
Infectious Diseases
Vol. 1, Issue 2, 2013 October 08, 2013 EDT

Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States

Emily Durden , Donna McMorrow , Paul Juneau , Robert Fowler , Paresh Chaudhari , David Horn ,
  • treatment
  • costs
  • burden
  • economic
  • aspergillosis
ccby-4.0 • https://doi.org/10.36469/9862
JHEOR
1.
Durden E, McMorrow D, Juneau P, Fowler R, Chaudhari P, Horn D. Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States. JHEOR. 2013;1(2):151-162. doi:10.36469/9862
Save article as...▾
  • PDF
  • XML
  • Citation (BibTeX)
Powered by Scholastica, the modern academic journal management system